Recent Updates — WORX
The Nasdaq Hearings Panel granted SCWorx Corp.'s request for reconsideration of its September 17 delisting decision, determining the company has regained compliance with Nasdaq's minimum bid price and publicly held shares requirements. Trading in the common stock, suspended since April 2026, will be reinstated on a date to be scheduled by Nasdaq after the company submits the required reinstatement form. As a condition of continued listing, investors in a September private placement waived their termination rights related to the prior delisting determination, and the Panel imposed a one-year Discretionary Panel Monitor ending October 2027 requiring monthly reporting on shareholdings. SCWorx Corp. provides data management solutions to healthcare providers.
SCWorx Corp. entered into a Securities Purchase Agreement on September 16, 2026, to sell 350,000 shares of common stock and accompanying warrants in a private placement to ten accredited investors. The aggregate gross proceeds were $938,000 at a combined price of $2.68 per share and warrant. Each warrant allows for the purchase of one additional share at an exercise price of $2.56 and expires five years after issuance. Dawson James Securities acted as placement agent, receiving 49,860 fee shares (9.99% of post-closing outstanding shares), up to $50,000 in expense reimbursements, and a 5.0% cash fee on proceeds. The company must file an S-3 registration statement within 30 days. SCWorx Corp. operates in the healthcare information technology industry, providing software solutions for skilled nursing facilities.
SCWorx Corp. received formal notification from Nasdaq on September 2, 2026, that it no longer satisfies the minimum publicly held shares requirement for continued listing, having only 89,782 such shares. This deficiency stems from a 1-for-12 reverse stock split effective August 3, 2026, which reduced public float below the required 500,000 shares. Consequently, Nasdaq rules prevent SCWorx from being considered compliant with the minimum bid price requirement until it first regains compliance with the publicly held shares requirement and subsequently maintains a closing bid price of at least $1.00 for ten consecutive business days. The company also remains non-compliant with the market value of publicly held shares requirement, facing a compliance period expiring January 20, 2027. SCWorx intends to submit views to the Nasdaq Hearings Panel by September 9, 2026, and is evaluating alternatives such as issuing additional common stock to regain compliance, though no specific plan has been determined. SCWorx Corp. operates in the healthcare technology industry, providing software solutions for community health centers.
SCWorx Corp. filed a Certificate of Amendment to its Certificate of Incorporation with the State of Delaware on July 28, 2026, effecting a 1-for-12 reverse stock split of its common stock. The transaction becomes effective at 11:59 p.m. Eastern Time on August 3, 2026. Consequently, every twelve outstanding shares will combine into one share, reducing the expected outstanding count from approximately 1,066,918 to roughly 89,000 shares. Fractional shares are rounded up to whole shares. The company states this action aims to satisfy Nasdaq Hearings Panel conditions regarding the minimum bid price requirement by August 28, 2026. However, the split reduces publicly held shares below Nasdaq's 500,000 share minimum and does not address a separate deficiency in market value of publicly held shares. SCWorx Corp. operates in the healthcare information technology sector.
SCWorx Corp. received a partial compliance letter from the Nasdaq Hearings Panel confirming it met the first condition of its plan to regain listing on The Nasdaq Capital Market, which required shareholder approval for a reverse stock split by July 22, 2026. The company must now effectuate the reverse stock split by August 3, 2026, and demonstrate a closing bid price of at least $1.00 per share for twenty consecutive trading days by August 28, 2026. SCWorx operates in the healthcare technology industry, providing data normalization and supply chain solutions.
SCWorx Corp. received a notice from Nasdaq on July 24, 2026, indicating that its Market Value of Publicly Held Shares (MVPHS) failed to maintain the minimum requirement of $1 million for the last 30 consecutive business days ending July 23, 2026. The company has been granted an 180-day compliance period through January 20, 2027, during which it must demonstrate MVPHS of at least $1 million for ten consecutive business days to regain listing standards. SCWorx is currently evaluating alternatives to satisfy these requirements but has not yet determined a specific course of action. Failure to comply could result in delisting from Nasdaq, though the company retains the right to appeal such a determination. SCWorx Corp. operates in the healthcare technology industry, providing software solutions for senior living communities.